in the news...

 

 

NanoMedTrix: UI Faculty Innovators Program success story

May 26, 2021: University of Iowa John Pappajohn Entreprenurial Center

NanoMedTrix went from winning pitch competitions to winning multi-million dollar grants, with a little help from JPEC's Faculty Innovators program. 

Read More

 

Small packages: UI nanotechnology firm gets $2 million boost in fight against cancer

May 17, 2021: Corridor Business Journal / Katharine Carlon

Eastern Iowa corridor spinoff continues to validate the clinical significance of the novel theranostic. 

Read More

 

NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa (formerly Iowa Innovation Corporation). 

March 8, 2021

The funding supplements the NIH Phase II award, in particular commercialization efforts related to establishing a clinical trial network.

Read More

 

UI spin-off NanoMedTrix awarded $2 million from National Cancer Institute. 

March 3, 2021: University of Iowa College of Engineering release

The SBIR grant is designed to bring the technology beyond the theoretical phase and closer to clinical trials for the treatment of bladder cancer.

Read More

 

Corridor startup NanoMedTrix seeking new rounds of private funding following NIH Phase II award. 

March 2, 2021: Clay and Milk, covering Iowa's startup, tech, and entreprenurial communities

New private capital investment matched with NIH Phase IIb would fund future clinical trials for novel bladder cancer therapeutic.

Read More

 

NanoMedTrix receives Judges' Choice award at Iowa Innovation Challenge Fall 2020 Elevator Pitch Competition. 

December 1, 2020: University of Iowa John Pappajohn Entreprenurial Center

The competition brings funds and recognition to companies started by University of Iowa faculty and students.

Read More

 

NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Iowa Innovation Corporation. 

September 5, 2019

The funding provides grant assistance for submission of an SBIR Phase II grant to the NCI for continued development of a novel bladder cancer therapeutic.

Read More

 

NanoMedTrix selected for participation in the NIH I-Corps(TM) program. 

December 23, 2018

The startup "bootcamp" is an intensive 8 week program designed to help biotech entrepreneurs identify and reach out to potential customers, partners.

Read More

 

NanoMedTrix awarded $295,000 from National Cancer Institute. 

September 7, 2018

The SBIR Phase I will evaluate the clinical and commercial potential of NanoMedTrix technology in the diagnosis and treatment of bladder cancer.

Read More

 

NanoMedTrix, UI research spinoff firm, wins first-of-its-kind grant.  The goal is to help physicians make early detection of cancer. 

August 7, 2013: University of Iowa Now

NanoMedTrix, a 2-year-old Coralville firm based upon University of Iowa research that may one day save lives by helping physicians identify bladder and colon cancers at early stages of development, recently received a grant that is the first of its kind.

Read More

 

UI research evolves into business The birth of NanoMedTrix.

NanoMedTrix is developing a product that would use nanoparticles, which are 1,000 times smaller than the width of a human hair, to help with diagnosing bladder and colon cancer.

Read More

 

NanoMedTRIX Awarded a prestigious NSF SBIR grant Phase I (2014-15)

Read More

 

NanoMedTRIX Awarded NSF SBIR grant Phase Ib (2014-15)

Read More

 

NanoMedTRIX Awarded a University of Iowa SBIR Matching grant (2015)

Read More

 

Internship Grant from Iowa Economic Development (Summer 2015)

Read More

 

Grant from Iowa Economic Development For SBIR Submission Award (2015)

Read More

 

DEMO Grant from Iowa Economic Development (2014)

Read More

 

GAP Grant from Iowa Economic Development/University of Iowa (2013)

Read More